Enhancing the Medical Expenditure Panel Survey (MEPS) for Cancer Survivorship Res
Enhancing the Medical Expenditure Panel Survey (MEPS) for Cancer Survivorship Res
批准号:
8176679
负责人:
金额:
$39.5万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAgeAgreementAmerican Cancer SocietyCancer ControlCancer SurvivorCancer SurvivorshipCenters for Disease Control and Prevention (U.S.)DataExpenditureFamilyFinancial SupportFundingGiftsHealth ExpendituresHealth ProfessionalHealthcareHouseholdIndividualMalignant NeoplasmsMeasuresMedicaidMedicalNational Cancer InstituteNational Health Interview SurveyPatientsPhysiciansPopulationQuality of CareQuestionnairesResearch PersonnelRespondentSamplingSurveysUnited StatesUnited States Agency for Healthcare Research and QualityUnited States National Institutes of HealthWorkbehavioral/social sciencecancer carecancer therapycostinterestresponsesocial science research
中文摘要
这项协议的目的是让国家癌症研究所(NCI)为医疗支出小组调查(MEP)向医疗研究和质量机构(AHRQ)提供财政支持。该项目是NCI、疾病控制和预防中心(CDC)、国家卫生研究院行为和社会科学研究办公室(OBSSR)、卫生保健研究和质量机构(AHRQ)和美国癌症协会(ACS)共同努力的结果。NCI和CDC之间存在单独的机构内部协议。OBSSR与NCI之间完成了直接引文。为ACS基金设立了NCI捐赠基金。
医疗支出小组调查(MEPS)是由AHRQ对美国所有年龄段的平民非制度化人口进行的具有全国代表性的调查。欧洲议会议员从所有付款人(包括私人付款人、医疗补助、退伍军人管理局和自付)收集两年内医疗保健和医疗保健支出的综合数据。MEPS使用国家健康访谈调查(NHIS)作为样本框架,但只包括NHIS样本的一部分(约占家庭和个人的1/3)。
2010年,NHIS包括一项癌症控制补充,今年的NHIS年将作为该项目的样本框架。使用NHIS条件列表来识别癌症幸存者家庭(即回答您是否曾被医生或其他卫生专业人员告知您患有癌症或任何类型的恶性肿瘤?),这些家庭将被过度抽样,以供在2011年欧洲议会选举中选择。该项目团队将与欧洲议会调查人员密切合作,最终确定将被过度抽样的癌症幸存者人口。有年轻癌症幸存者(年龄在65岁以下)的家庭尤其令人感兴趣。癌症幸存者人数的增加将使人们能够对所有年龄段的癌症患者的癌症护理成本进行更完整、更具全国代表性的估计。
还将为癌症幸存者家庭编制有针对性的问卷,以解决癌症幸存者及其家人的癌症治疗和护理质量措施。这些问卷将在2011年和2012年发放。
英文摘要
The purpose of this agreement is for the National Cancer Institute (NCI) to provide financial support to the Agency for Healthcare Research and Quality (AHRQ) for the Medical Expenditure Panel Survey (MEPS). This project is a collaborative effort between the NCI, the Centers for Disease Control and Prevention (CDC), the Office of Behavioral and Social Science Research (OBSSR) of the National Institutes of Health, the Agency for Healthcare Research and Quality (AHRQ), and the American Cancer Society (ACS). A separate intra-agency agreement exists between the NCI and the CDC. A direct citation was completed between OBSSR and NCI. An NCI gift fund was established for ACS funds.
The Medical Expenditure Panel Survey (MEPS) is nationally representative survey of the civilian non-institutionalized population of all ages in the United States conducted by AHRQ. The MEPS collects comprehensive data on health care and health care expenditures from all payors (including private payors, Medicaid, the VA, and out-of-pocket) over a two year period. The MEPS uses the National Health Interview Survey (NHIS) as its sample frame, but includes only a subset of the NHIS sample (about ¿ to 1/3 of the households and individuals).
In 2010, the NHIS includes a cancer control supplement and this NHIS year will serve as the sample frame for this project. Using the NHIS condition list to identify households with cancer survivors (i.e., respondent with an affirmative response to ¿Have you ever been told by a physician or other health professional that you had cancer or a malignancy of any kind?¿), these households will be oversampled for selection in the 2011 MEPS. The project team will work closely with MEPS investigators to make the final determination of the populations of cancer survivors that will be over-sampled. Households with young cancer survivors (younger than age 65) are of particular interest. The added population of cancer survivors will allow for more complete, nationally representative estimates of the costs of cancer care for patients of all ages.
Targeted questionnaires for households with cancer survivors will also be developed to address cancer treatment and quality of care measures for cancer survivors and their families. These questionnaires will be fielded in 2011 and 2012.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: